ARAY earnings date and last-quarter result: next report 2026-08-19, last quarter miss, P/E -0.65. Updated 2026-07-23.
Accuray (ARAY) Research Hub
Accuray (ARAY) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-10-26, shares last closed at 0.1231 USD (-5.38%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.65, market cap 0.03B. This hub links to the full technical, earnings and options research available for ARAY.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.1231 USD (-5.38%) |
| 52-week range | 0.1225 USD – 0.382 USD |
| Trend regime | Range |
| 14-day RSI | 0 (Oversold) |
| Trailing P/E | -0.65 |
| Market cap | 0.03B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-19 |
Available research for ARAY
Covered Call on ARAY: how it works, illustrative setup around the real 0.1231 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ARAY: how it works, illustrative setup around the real 0.1231 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ARAY: how it works, illustrative setup around the real 0.1231 USD price, max profit/loss, breakeven and when to use it. Educational.
ARAY technical analysis: range, last 0.1231 USD, RSI 0, 52w range 0.1225 USD–0.382 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ARAY in?
Accuray (ARAY) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.
Is ARAY in an uptrend or downtrend?
As of 2026-10-26, ARAY is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ARAY's trailing P/E ratio?
ARAY's trailing P/E is -0.65, with a market cap of 0.03B. See the earnings research page for full valuation detail.
When does ARAY next report earnings?
ARAY is next scheduled to report earnings on 2026-08-19.